Detalhe da pesquisa
1.
Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.
J Virol
; 85(3): 1287-97, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21047964
2.
Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1.
Nat Med
; 11(11): 1170-2, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16205738
3.
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies.
Lancet
; 373(9672): 1352-63, 2009 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-19361855
4.
Prevalence- and gender-specific immune response to opportunistic infections in HIV-infected patients in Lesotho.
Sex Transm Dis
; 37(7): 454-9, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20531031
5.
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal.
Clin Infect Dis
; 48(8): 1138-51, 2009 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19275498
6.
Decrease of atazanavir and lopinavir plasma concentrations in a boosted double human immunodeficiency virus protease inhibitor salvage regimen.
Antimicrob Agents Chemother
; 52(6): 2273-5, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18411323
7.
Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapy.
Antivir Ther
; 13(7): 927-36, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19043927
8.
Pharmacokinetics, safety and efficacy of saquinavir/ ritonavir 1,000/100 mg twice daily as HIV type-1 therapy and transmission prophylaxis in pregnancy.
Antivir Ther
; 13(8): 1039-46, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19195329
9.
The steady-state pharmacokinetics of atazanavir/ritonavir in HIV-1-infected adult outpatients is not affected by gender-related co-factors.
J Antimicrob Chemother
; 62(3): 579-82, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18477709
10.
Platelet-leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors.
J Antimicrob Chemother
; 62(5): 1118-21, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18753189
11.
Switching from a toxicity-causing antiretroviral to enfuvirtide in patients with HIV: the SWITCH TOX study.
HIV Clin Trials
; 9(6): 375-86, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19203903
12.
[No obvious difference in Streptococcus pneumoniae antibiotic resistance profiles--isolates from HIV-positive and HIV-negative patients]. / Vergleichbare Antibiotikaresistenz von Pneumokokkenisolaten HIV-positiver und -negativer Patienten.
Med Klin (Munich)
; 103(2): 69-74, 2008 Feb 15.
Artigo
em Alemão
| MEDLINE | ID: mdl-18270662
13.
Chronic renal failure among HIV-1-infected patients.
AIDS
; 21(9): 1119-27, 2007 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-17502722
14.
The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitors.
AIDS
; 21(15): 2033-42, 2007 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17885293
15.
Quadruple nucleoside therapy with zidovudine, lamivudine, abacavir and tenofovir in the treatment of HIV.
Antivir Ther
; 12(5): 695-703, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17713153
16.
Predictive factors for response to a boosted dual HIV-protease inhibitor therapy with saquinavir and lopinavir in extensively pre-treated patients.
Antivir Ther
; 12(8): 1237-46, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-18240863
17.
Evolution of resistance mutations during low-level viral replication in HIV-1-infected patients treated with zidovudine/lamivudine/abacavir as a first-line regimen.
Antivir Ther
; 12(1): 25-30, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17503744
18.
Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts.
Antivir Ther
; 12(3): 325-33, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17591022
19.
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial.
Lancet
; 368(9534): 476-82, 2006 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-16890834
20.
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.
Lancet
; 368(9534): 451-8, 2006 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-16890831